Company Overview More
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of advanced or metastatic urothelial cancer; and TUKYSA, an oral small molecule tyrosine kinase inhibitor for the treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer. It also develops TIVDAK for metastatic cervical cancer and other solid tumors; Ladiratuzumab Vedotin, an ADC targeting LIV-1 for metastatic breast cancer and solid tumors; Disitamab Vedotin, a novel HER2-targeted ADC; and SEA-CD40, SEA-TGT, SEA-BCMA, and SEA-CD70 for various cancer diseases. Seagen Inc. has collaboration agreements with Takeda Pharmaceutical Company Limited; Agensys, Inc.; Genmab A/S; Merck; and RemeGen, Co. Ltd. The company was formerly known as Seattle Genetics, Inc. and changed its name to Seagen Inc. in October 2020. Seagen Inc. was incorporated in 1997 and is headquartered in Bothell, Washington.
CEO: Dansey M.D., Roger D.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Moomoo > Quotes > SGEN Seagen > Detailed Quotes

SGEN Seagen

144.830+9.200+6.78%
Trading Session 05/16 11:32 ET
High
145.360
Open
134.180
Turnover
82.90M
Low
134.140
Pre Close
135.630
Volume
586.55K
Market Cap
26.66B
P/E(TTM)
Loss
52wk High
192.787
Shares
184.08M
P/E(Static)
Loss
52wk Low
105.430
Float Cap
19.68B
Bid/Ask %
0.00%
Historical High
213.940
Shs Float
135.85M
Volume Ratio
0.92
Historical Low
2.150
Dividend TTM
--
Div Yield TTM
1100
P/B
8.89
Dividend LFY
--
Div Yield LFY
759.51%
Turnover Ratio
0.43%
Amplitude
8.27%
Avg Price
141.329
Lot Size
1
Float Cap
19.68B
Bid/Ask %
0.00%
Historical High
213.940
Shs Float
135.85M
Volume Ratio
0.92
Historical Low
2.150
Dividend TTM
--
P/B
8.89
Dividend LFY
--
Turnover Ratio
0.43%
Amplitude
8.27%
Avg Price
141.329
Lot Size
1
Price Forecast

Loading...

News

Comment